K. Blumenstengel

Two years rituximab maintenance vs. observation after first-line treatment with bendamustine plus rituximab (B-R) in patients with mantle cell lymphoma: First results of a prospective, randomized, multicenter phase II study (a subgroup study of the StiL NHL7-2008 MAINTAIN trial).

Mathias Rummel, Wolfgang Knauf, Martin Göerner et al. · Journal of Clinical Oncology · 2016 · 87 citations

Medicine, Hematology, Oncology +8

Deferasirox treatment of iron‐overloaded chelation‐naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjange

Norbert Gattermann, Andrea Jarisch, Rudolf Schlag et al. · European Journal Of Haematology · 2011 · 38 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma

Eva Herrmann, Norbert Marschner, Marc‐Oliver Grimm et al. · World Journal of Urology · 2011 · 26 citations

Medicine, Oncology, Pharmacology +14